1. Management of COPD in Asia: A position statement of the Asian Pacific Society of Respirology.
- Author
-
Rhee CK, Chau NQ, Yunus F, Matsunaga K, and Perng DW
- Subjects
- Air Pollution adverse effects, Asia epidemiology, Body Mass Index, Female, Humans, Male, Parasitic Diseases complications, Prevalence, Pulmonary Disease, Chronic Obstructive diagnosis, Pulmonary Disease, Chronic Obstructive physiopathology, Respiratory Function Tests statistics & numerical data, Risk Factors, Smoke adverse effects, Smoking adverse effects, Tuberculosis, Pulmonary complications, Bronchiectasis epidemiology, Pulmonary Disease, Chronic Obstructive epidemiology, Pulmonary Disease, Chronic Obstructive therapy
- Abstract
Chronic obstructive pulmonary disease (COPD) is a major disease in Asia. However, how to manage specifically Asian COPD patients has not been proposed. Awareness of COPD is very low and underdiagnosis/undertreatment is common in Asian countries. Low utilization of pulmonary function test and inhalers is also a problem. Moreover, high smoking prevalence and air pollution are barriers to managing Asian patients with COPD. The relatively low body mass index of Asian patients with COPD can increase their risk for experiencing adverse effects from COPD drugs. Physicians should consider the unique features of Asian populations with COPD such as the high prevalence rates of bronchiectasis and tuberculosis-destroyed lungs, biomass smoke exposure and parasitic infection., (© 2019 Asian Pacific Society of Respirology.)
- Published
- 2019
- Full Text
- View/download PDF